Hjem › Højt blodtryk › Oklahoma
Højt blodtryk kliniske forsøg i Oklahoma
9 studier for Højt blodtryk søger deltagere på steder i Oklahoma.
Byer i Oklahoma
Officiel studietekst (engelsk)
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
- CRO Call Center, Tulsa
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07142356BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- South Oklahoma Heart Research, Oklahoma City
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06059638A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Oklahoma Heart Institute, Tulsa
Rekrutterer
Alder 18 til 85 · Alle køn · Opdateret 1. okt. 2026 · NCT07214376EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Tekton Research Oklahoma City, Oklahoma City
- South Oklahoma Heart Research Group, Oklahoma City
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07064473A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Central States Research, Tulsa
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07794579THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- Ascension St. John Clinical Research Institute, Bartlesville
Rekrutterer
Alder 22 til 75 · Alle køn · Opdateret 24. sep. 2026 · NCT06559891Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Edmond
- Clinical Trial Site, Moore
- Clinical Trial Site, Norman
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT07181109An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- Conrad Clinical Research, Edmond
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. jul. 2026 · NCT07543120Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, Norman
- Vanda Investigative Site, Oklahoma City
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 27. feb. 2026 · NCT07090161Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.